COBAS B 221<6>=ROCHE OMNI S6 SYSTEM 03337154001

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,06 report with the FDA on 2013-04-29 for COBAS B 221<6>=ROCHE OMNI S6 SYSTEM 03337154001 manufactured by Roche Diagnostics.

Event Text Entries

[10733917] Databases received from the customer show quality controls were within range. Calibration values were also acceptable. Comparison measurements with a retention sample of lot 25124850 were performed and were within specification. Batch records were reviewed and no abnormalities were found. A quality issue could not be verified with mss-g/l/u sensor lot 21524850. The customer also measures fluoride samples. Data provided showed higher signals at the interference sensor which indicates use of an unsuitable anticoagulant. Labeling indicates that the only clot inhibitors that may be used for analyses on the cobas b221 system are heparin salts. Other clot inhibitors, such as fluoride have significant influence on blood's ph and other parameters.
Patient Sequence No: 1, Text Type: N, H10


[11493754] Medwatch (manufacturing site) was updated.
Patient Sequence No: 1, Text Type: N, H10


[15017874] The customer reported that they received an erroneous result for one patient sample tested for glucose. The capillary sample initially resulted as 3. 3 mmol/l and this value was reported outside of the laboratory. A fluoride sample from the same patient was tested on the laboratory chemistry analyzer and this sample resulted with a glucose value of 1. 7 mmol/l which was reported to the ward. The customer was not sure of the timing of the fluoride sample and how close it was to the measurement of the capillary sample. A sample from the patient was also tested on an inform ii meter and this resulted as 1. 9 mmol/l. It is unknown if the sample tested on the inform ii meter is the same capillary sample that was initially tested or if it was a different sample. Treatment for hypoglycemia was delayed for the patient as a result of the issue. The patient received treatment after the laboratory result of 1. 7 mmol/l was received by the ward. The patient was not adversely affected by the event. The lot number of the glucose/lactate cassette was 21524850. The expiration date was not provided.
Patient Sequence No: 1, Text Type: D, B5


[15280358] This event occurred in the (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[21309192] The date received by manufacturer is (b)(4) 2013.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2013-02587
MDR Report Key3081707
Report Source01,05,06
Date Received2013-04-29
Date of Report2014-02-03
Date of Event2013-03-07
Date Mfgr Received2013-04-05
Date Added to Maude2013-04-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location3
Manufacturer ContactNA JENNIFER WOLFGRAM
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175217008
Manufacturer G1ROCHE INSTRUMENT CENTER AG TEGIMENTA
Manufacturer StreetFORRENSTRASSE NA
Manufacturer CityROTKREUZ 6343
Manufacturer CountrySZ
Manufacturer Postal Code6343
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameCOBAS B 221=ROCHE OMNI S6 SYSTEM
Generic NameBLOOD GAS ANALYZER
Product CodeJJC
Date Received2013-04-29
Model NumberNA
Catalog Number03337154001
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2013-04-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.